Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

NCT06375239 · clinicaltrials.gov ↗
RECRUITING
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ray Therapeutics, Inc.

Collaborators